Therapy News and Research

RSS

Viagra significantly reduces stress on the heart

According to the results of a new study by researchers at Johns Hopkins, Viagra, a drug used to treat erectile dysfunction (ED) in millions of men, reduces the stimulatory effects of hormonal stress on the heart by half.

25 Oct 2005

Despite warning dangerous ADHD drug still being sold

According to the U.S. Food and Drug Administration, liver problems linked to the attention deficit drug Cylert and other generic versions of the drug make it too dangerous for the U.S. market.

25 Oct 2005

Physical and emotional impact of breast cancer

The psychological and physical effects of breast cancer are being examined in a first-time study that tracks women in the first five years following their diagnosis.

25 Oct 2005

Viagra may be the next drug treatment for heart problems

Sildenafil citrate (Viagra), a drug used to treat erectile dysfunction (ED) in millions of men, reduces the stimulatory effects of hormonal stress on the heart by half, according to results of a new study by researchers at Johns Hopkins.

24 Oct 2005

St. John's wort plant has the capacity to inhibit expression of the HIV-1 gene

A novel protein, p27SJ, extracted from a callus culture of the St. John's wort plant (Hypericum perforatum) suppresses HIV-1 expression and inhibits its replication, according to researchers at Temple University School of Medicine's department of neuroscience and Center for Neurovirology (CNV).

24 Oct 2005

Survival benefits of longer-term tamoxifen use may take years to appear

The survival benefits of longer-term therapy using tamoxifen may take at least nine years to develop, according to a new study published in the December 1, 2005 issue of Cancer, a peer-reviewed journal of the American Cancer Society.

24 Oct 2005

Women on breast cancer treatment opt for injections to curb hot flashes

Apparently, given a choice, many breast cancer patients using hormone therapies such as Tamoxifen to cut the risk of recurrence, would opt for pills rather than injections.

24 Oct 2005

Testosterone may improve women's sex lives after menopause

The addition of testosterone to hormone therapy in women after menopause enhances their sexual function. However, it may also reduce HDL cholesterol (the "good" cholesterol) in women, according to a systematic review of current evidence.

23 Oct 2005

Traditional medical treatment of persistent cough may not be the most effective

The reviews appear in the current issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic.

23 Oct 2005

Nitric oxide may help sickle cell patients

Inhaling a small dose of nitric oxide gas may one day help sickle cell patients avoid pain crises and live healthier lives, researchers say.

23 Oct 2005

New treatment advances for patients with follicular lymphoma

A newly published study recommends that doctors carefully choose their patients' initial therapies because there are significant differences in overall survival rates, according to researchers at the University of Rochester Medical Center's James P. Wilmot Cancer Center.

20 Oct 2005

Successful prevention programs for children and adolescents

The future is bleak for children whose behavior seriously goes against the norm at a tender age. Early and long-term interventions make all the difference.

20 Oct 2005

Researchers learn to rapidly rebuild immunity in immune-suppressed cancer patients

Patients with multiple myeloma suffer from a malignant proliferation of plasma cells in their bone marrow. The standard treatment for this form of cancer is high-dose chemotherapy and transplantation of one's own blood-producing adult stem cells; however, this aggressive treatment wipes out the mature immune-system cells of patients – leaving them vulnerable to infection.

20 Oct 2005

Link between emotional impairment and poor cognition in children with bipolar disorder

Using functional magnetic resonance imaging, Pavuluri and her colleagues examined the brain activity of teens while they were performing certain mental tasks. The researchers scanned the brains of 10 unmedicated bipolar patients with normal mood and compared them with 10 healthy subjects of the same age and gender.

20 Oct 2005

Diet rich in fruits and vegetables could be a good defense against prostate cancer

Previous studies have suggested that increased intake of flavonoids which are common in fruits and vegetables may be associated with a reduced risk of prostate cancer, according to Sanjay Gupta, Ph.D., an assistant professor in the Case School of Medicine Department of Urology.

20 Oct 2005

Shaped-beam radiation therapy is a promising treatment for life-threatening metastatic liver tumors

...according to researchers at the University of Rochester Medical Center who report an 88 percent success rate for controlling the lesions. This is the first evidence that doctors can treat these tumors with radiation, and the results doubled the average length of survival.

19 Oct 2005

Herceptin results "quite remarkable"

The targeted drug trastuzumab, or Herceptin, previously shown to prolong survival in advanced breast cancer, dramatically reduced the chances of recurrence in patients with early-stage disease when given for one year following standard chemotherapy.

19 Oct 2005

Survival rate of HIV-infected patients in India has risen in response to a 20-fold drop in the price of antiretroviral therapy

Many of the more than 5 million HIV-infected people living in India have been unable to obtain treatment due to the high cost. With the introduction of generic ART into India in 2000, the price of HIV drugs fell from $778 per month to $100 per month, and eventually declined even further to just $33 per month in 2003.

19 Oct 2005

Herceptin therapy highly superior to standard breast cancer treatment

In a joint paper, co-authored by Mayo Clinic's Edith Perez, M.D., and Edward Romond, M.D., of the National Surgical Adjuvant Breast and Bowel Project (NSABP), researchers report complete and combined results of two trials comparing adjuvant chemotherapy with or without concurrent trastuzumab treatment in women with surgically removed HER2-positive breast cancer.

19 Oct 2005